Fennec Pharmaceuticals Inc (FENC) Stock Price, Quote & News

Company Profile

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium...

Industry: Biotechnology

Sector: Healthcare

Phone: 919 636 4530

Website: www.fennecpharma.com

Address:

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, United States

Nosh Aug. 13 at 1:24 PM

$FENC Watch

0 · Reply

JackCampbell Aug. 12 at 11:37 AM

$FENC just turned into profitability... watch this steadily growing in the next qoq´s and yoy´s! Running from record to record the next yrs to come!

0 · Reply

topstockalerts Aug. 11 at 8:05 PM

$FENC that was a very respectable bounce

0 · Reply

StocktwitsNews Aug. 11 at 6:06 PM

FENC Q2 2026 Earnings Summary $FENC https://stocktwits.com/news/earnings/ai summaries/fenc-q2-2026-earnings-summary/cZoNdQDRJXg

0 · Reply

Nosh Aug. 11 at 5:58 PM

$FENC Watch...

0 · Reply

prismmarketview Aug. 11 at 4:03 PM

Prism Mid-Day Movers: MedTech and Cybersecurity are Today’s Leaders. Neuronetics, Inc. (NASDAQ: $STIM ) is surging today, up 35.25% to 2.935 after reporting stronger-than-expected second-quarter results. Rapid7, Inc. (NASDAQ: $RPD ) is climbing sharply today, rising 21.23% to 14.075 from its previous close of 11.61. The cybersecurity company opened at 12.825, hit an intraday high of 14.795, and has traded roughly 2.89 million shares—well above its recent average volume. Other Notable Movers: Aurora Cannabis Inc. ( $ACB ) up 20% Fennec Pharmaceuticals INC. ( $FENC ) UP 10% PDS Biotechnology Corp. ( $PDSB ) down -60% Disclaimer: Stock prices and percentage changes are as of 11:55 p.m. ET on August 11, 2026 and are subject to change throughout the trading day. Market data may be delayed, and intraday price movements can change rapidly. Please verify current quotes with your broker or financial data provider before making any investment decisions. https://prismmarketview.com/prism-mid-day-movers-medtech-and-cybersecurity-are-todays-leaders/

0 · Reply

EarningsInsider Aug. 11 at 1:32 PM

https://www.marketbeat.com/earnings/reports/2026-8-11-fennec-pharmaceuticals-inc-stock/ $FENC Adherex Technologies Earnings Transcript

0 · Reply

JackCampbell Aug. 11 at 1:13 PM

$FENC beat on both - EPS and revenue!!

0 · Reply

OpenOutcrier Aug. 11 at 12:44 PM

$FENC (+5.3% pre) Fennec Pharmaceuticals surges 8% on Q2 earnings, revenue beat https://ooc.bz/l/110782

0 · Reply

StocktwitsEarnings Aug. 11 at 12:27 PM

$FENC Q2 '26 Earnings Results & Recap Fennec Pharmaceuticals recorded $17.1 million in net product sales for Q2 2026, up 78% year over year, and achieved $2.8 million in non-GAAP adjusted EBITDA for the quarter.

0 · Reply

Fennec Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Fennec Pharmaceuticals Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Fennec Pharmaceuticals Quarterly report: Q2 2026

Aug 5, 2026, 7:01 AM EDT - 14 days ago

Market Cap	414.74M
Revenue (ttm)	44.64M
Net Income (ttm)	-9.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	40.07
Profit Margin	-21.82%
Debt to Equity Ratio	0.00

Volume	114,505
Avg Vol	218,408
Day's Range	N/A - N/A
Shares Out	35.06M
Stochastic %K	51%
Beta	1.09
Analysts	Strong Sell
Price Target	$16.50